Pre-Open Stock Movers

Protalix BioTherapeutics, Inc. (NYSE: PLX) 42% LOWER; announced that they received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Biologics License Application (BLA) seeking accelerated approval of pegunigalsidase alfa (PRX‑102) for the proposed treatment of adult patients with Fabry disease.

ADMA Biologics, Inc. (Nasdaq: ADMA) 20% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted approval for the Companys expanded manufacturing process, enabling fractionation and purification of a 4,400-liter plasma pool for the manufacture of Intravenous Immune Globulin (IVIG).

Pinterest (NYSE: PINS) 11% LOWER; reported Q1 EPS of $0.11, $0.04 better than the analyst estimate of $0.07. Revenue for the quarter came in at $485 million versus the consensus estimate of $473.66 million.

RR Donnelley (NYSE: RRD) 8.6% LOWER; reported Q1 EPS of $0.08, $0.07 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $1.17 billion versus the consensus estimate of $1.12 billion.

Genpact Limited (NYSE: G) 8% HIGHER; will replace Genworth Financial Inc. (NYSE: GNW) in the S&P MidCap 400

Spotify (NYSE: SPOT) 8% LOWER; reported Q1 EPS of (EUR0.25), versus (EUR0.20) reported last year. Revenue for the quarter came in at EUR2.15 billion, versus EUR1.85 billion reported last year.

Discovery, Inc (NASDAQ: DISCA) 7.6% LOWER; reported Q1 EPS of $0.21, which may not compare to the analyst estimate of $0.65. Revenue for the quarter came in at $2.79 billion versus the consensus estimate of $2.77 billion.

GSX Techedu Inc. (NYSE: GSX) 7% HIGHER; Goldman Sachs upgraded from Sell to Buy with a price target of $60.00 (from $70.00).

Enphase Energy (NASDAQ: ENPH) 7% LOWER; reported Q1 EPS of $0.56, $0.11 better than the analyst estimate of $0.45. Revenue for the quarter came in at $301.8 million versus the consensus estimate of $292.23 million. Enphase Energy sees Q2 2021 revenue of $300-320 million, versus the consensus of $320.9 million.

Aurora Mobile Ltd. (NASDAQ: JG) 6.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $6.00.

F5 Networks (NASDAQ: FFIV) 6% LOWER; reported Q2 EPS of $2.50, $0.11 better than the analyst estimate of $2.39. Revenue for the quarter came in at $645 million versus the consensus estimate of $635.98 million. F5 Networks sees Q3 2021 EPS of $2.36-$2.54, versus the consensus of $2.50. F5 Networks sees Q3 2021 revenue of $620-650 million, versus the consensus of $635.17 million.

BioVie Inc. (NASDAQ: BIVI) 5.9% HIGHER; announced the acquisition of the biopharmaceutical assets of NeurMedix, Inc., (NeurMedix), a San Diego based privately held clinical-stage pharmaceutical company focused on novel therapeutic assets for the treatment of neurodegenerative and neurological disorders, as well as certain cancers.

Boyd Gaming (NYSE: BYD) 5.5% HIGHER; reported Q1 EPS of $0.93, $0.49 better than the analyst estimate of $0.44. Revenue for the quarter came in at $753.3 million versus the consensus estimate of $673.13 million.

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) 4.3% HIGHER; reported Q1 EPS of $26.29, $10.41 better than the analyst estimate of $15.88. Revenue for the quarter came in at $55.31 billion versus the consensus estimate of $51.68 billion.

Mondelez (NASDAQ: MDLZ) 3.7% HIGHER; reported Q1 EPS of $0.77, $0.08 better than the analyst estimate of $0.69. Revenue for the quarter came in at $7.24 million versus the consensus estimate of $7.02 million.

Amgen (NASDAQ: AMGN) 3.5% LOWER; reported Q1 EPS of $3.70, $0.35 worse than the analyst estimate of $4.05. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $6.25 billion. Amgen sees FY2021 EPS of $16.00-$17.00, versus the consensus of $16.80. Amgen sees FY2021 revenue of $25.8-26.6 billion, versus the consensus of $26.41 billion.

Advanced Micro Devices, Inc. (NASDAQ: AMD) 3.4% HIGHER; reported Q1 EPS of $0.52, $0.08 better than the analyst estimate of $0.44. Revenue for the quarter came in at $3.45 billion versus the consensus estimate of $3.21 billion. Advanced Micro Devices, Inc. sees Q2 2021 revenue of $3.5-3.7 billion, versus the consensus of $3.3 billion.

Microsoft (NASDAQ: MSFT) 2% LOWER; reported Q3 EPS of $1.95, $0.17 better than the analyst estimate of $1.78. Revenue for the quarter came in at $41.7 billion versus the consensus estimate of $41.03 billion.

Starbucks (NASDAQ: SBUX) 2% LOWER; reported Q2 EPS of $0.62, $0.09 better than the analyst estimate of $0.53. Revenue for the quarter came in at $6.67 billion versus the consensus estimate of $6.82 billion. Q2 Comparable Store Sales Growth of 9% in the U.S. Starbucks sees FY2021 EPS of $2.90-$3.00, versus the consensus of $2.85. Starbucks sees FY2021 revenue of $28.5-29.3 billion, versus the consensus of $28.6 billion.